Form 4: Clene Inc. Director Matthew Kiernan Acquires Stock Options

Clene Inc. director Matthew Kiernan was granted stock options for 2,853 shares of common stock at an exercise price of $4.40 per share.

Summary

• Matthew Kiernan, a director at Clene Inc., was granted stock options on December 6, 2024.
• The options are for 2,853 shares of common stock.
• The exercise price for these options is $4.40 per share.
• The options vest immediately upon grant.
• The options expire on December 5, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of granting stock options to directors, which is generally viewed positively as it aligns interests. There is no indication of any negative or unusual activity.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• Immediate vesting of the options may incentivize the director to contribute to the company's success.

Industry Context

This is a standard practice for companies to incentivize directors and align their interests with shareholders through equity-based compensation.

Comparison to Industry Standards

• Stock option grants to directors are a common practice across the industry.
• The vesting schedule of immediate vesting is not uncommon, but can vary depending on the company's compensation policies.
• The exercise price of $4.40 is specific to Clene Inc. and would need to be compared to the current market price of the stock to assess its value.

Stakeholder Impact

• The stock option grant may have a slightly positive impact on shareholder sentiment as it aligns director interests with company performance.

Key Dates

Keywords

stock options, insider trading, beneficial ownership, director, Clene Inc., equity